Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News iShares Silver Trust SLV

The investment seeks to reflect generally the performance of the price of silver. The Trust seeks to reflect such performance before payment of the Trusts expenses and liabilities. It is not actively managed. The Trust does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.

Recent & Breaking News (ARCA:SLV)

Selvita Group reports over a two-fold increase in revenues for Q1 2021

PR Newswire May 26, 2021

Breakthrough year in the development of Selvita - strategic acquisition & strong financial results

PR Newswire March 30, 2021

Selvita reports strong financial results for H1 2020 and a record backlog

PR Newswire September 10, 2020

Selvita Raised Over EUR 20 Million in Its Follow-on Public Offer

PR Newswire June 3, 2020

The Share Issue Price in Selvita Public Offering Set at PLN 38

PR Newswire May 28, 2020

Selvita Extraordinary General Shareholder Meeting Decides to Proceed With the Follow-on Share Issue Initiation of the Book-building Process on Wednesday, May 27

PR Newswire May 26, 2020

Selvita Reports Financial Results for Q1 2020: Dynamic Increase in Backlog for 2020 and Strong Position on the Market

PR Newswire May 26, 2020

Selvita Announces Its New Development Strategy for 2020 - 2023

PR Newswire April 29, 2020

Selvita and Ardigen Will Receive Funding for the Development of an AI-based High-content Screening Platform

PR Newswire April 27, 2020

Selvita 2019 Financial Results: Accelerated Growth, 43 Percent Increase in Commercial Revenues and a Very Solid Backlog for 2020

PR Newswire March 26, 2020

Ryvu Therapeutics and Selvita Announce Registration of Corporate Split by the National Court Register of Poland

PR Newswire October 1, 2019

Selvita Announces Shareholder Approval of Corporate Split and New Name of Ryvu Therapeutics for Oncology Development Company

PR Newswire September 19, 2019

Selvita Announces First Patient Dosed in Phase 1b Study of CDK8 Inhibitor SEL120 in the Treatment of Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

PR Newswire September 6, 2019

Selvita Reports Second Quarter and Half-year 2019 Financial Results

PR Newswire September 5, 2019

Polish Financial Supervision Authority Approves Selvita CRO Prospectus, Allowing Corporate Split Into Two Separately Listed Companies to Proceed

PR Newswire September 3, 2019

Selvita to Present at Upcoming Conferences in September

PR Newswire September 3, 2019

Selvita Appoints Setareh Shamsili, M.D., Ph.D., as Chief Medical Officer

PR Newswire July 25, 2019

Selvita Reports First Quarter 2019 Financial Results and Provides Corporate Update

PR Newswire May 22, 2019

Selvita to Present at the UBS 2019 Global Healthcare Conference in New York

PR Newswire May 13, 2019

Selvita and The Leukemia & Lymphoma Society Announce Partnership to Advance SEL120 Into Phase I for AML Patients

PR Newswire August 8, 2017